FDA expands use of Novartis vaccine; New hep C model opens door for vaccine;

> FDA has approved the use of Novartis' ($NVS) quadrivalent meningococcal vaccine in infants as young as 2 months old. Release

> A new hepatitis C model could help develop a vaccine to tackle the virus. Item

> A New York Times op-ed has highlighted how vaccines have helped apes. Op-ed

> NIH has awarded TechnoVax $600,000 towards development of a universal influenza vaccine. News

> Emergent BioSolutions has won approval to market its anthrax vaccine in Germany. Article

> Officials from 17 countries have met in Dakar to discuss sustainable immunization financing programs. Piece

> Immunovaccine has obtained a $5 million loan to support clinical trials of its cancer vaccines. Item

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.